Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02498379 · ClinicalTrials.gov registry record · Early Phase 1
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)
A Early Phase 1 study, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 8
- Enrollment target
NCT02498379: Completed Early Phase 1 study, sponsored by Washington University School of Medicine.
NCT02498379 is a Early Phase 1 study that has completed, run by Washington University School of Medicine. The registered enrollment target is 8 participants, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02498379, a Early Phase 1 study, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 8 participants
- Enrollment target
Study Summary
This study is designed to assess the safety, biodistribution and dosimetry of the novel atherosclerotic imaging PET radiotracer, Cu\[64\]-25%-CANF-Comb.
Primary Outcome
Biodistribution by PET-CT (Cu\[64\]-25%CANF-Comb uptake in blood, liver, kidneys, spleen, heart, bone, muscle); Amount of radioactive tracer in the blood and urine; Difference in physical examination findings, vital signs, serum and urine laboratory values and EKG results from baseline.
Interventions
- DRUG Cu[64]-25%CANF-Comb
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2014-10 |
| Est. Completion | 2015-04 |
| Phase | Early Phase 1 |
What the finished NCT02498379 record still lists
NCT02498379 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 1 intervention - of which Cu[64]-25%CANF-Comb is the first listed.
NCT02498379 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02498379 about?
NCT02498379 is a clinical study titled "PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)". This study is designed to assess the safety, biodistribution and dosimetry of the novel atherosclerotic imaging PET radiotracer, Cu\[64\]-25%-CANF-Comb.
What is the current status of trial NCT02498379?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 8 participants. The study started on 2014-10. Estimated completion is 2015-04.
What interventions are being tested in trial NCT02498379?
The interventions under investigation include: Cu[64]-25%CANF-Comb (DRUG).
Who is sponsoring clinical trial NCT02498379?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02498379's enrollment target sits among peer trials
8 1783rd of 2000 higher than 176 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia